Results 11 to 20 of about 14,940 (200)

The Impact of Inoculum Size on the Activity of Cefoperazone-Sulbactam Against Multidrug Resistant Organisms

open access: yesJournal of Microbiology, Immunology and Infection, 2018
Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms.
Chuang Yin-ching   +2 more
exaly   +4 more sources

Triggering SORL1 Expression Restricts ccRCC Progression by Inducing Ubiquitination‐Mediated c‐Myc Degradation [PDF]

open access: yesCancer Science, EarlyView.
Targeted triggering of SORL1 expression through a novel MPOC delivery system could inhibit ccRCC progression through binding to TRIM22 and further promoting ubiquitination‐mediated C‐MYC degradation, thereby facilitating the inhibition of oxidative phosphorylation through transcriptional repression of ACO2 and IDH2.
Keyi Wang   +11 more
wiley   +2 more sources

Hypersensitivity vasculitis induced by cefoperazone/sulbactam [PDF]

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2003
Background Cefoperazone has not been reported to cause vasculitic complications before. Here, we report a case of hypersensitivity vasculitis associated with cefoperazone/sulbactam.
Ariturk Ender   +4 more
doaj   +2 more sources

Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan

open access: yesJournal of Medical Sciences, 2016
Background: The multidrug-resistant Gram-negative bacteria (MDRGNBs) have emerged as important pathogens recently. Cefoperazone-sulbactam is active against a great proportion of those MDRGNBs.
Tsung-Ta Chiang   +7 more
doaj   +2 more sources

Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

open access: yesFrontiers in Medicine, 2021
There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia.
Yanli Ji, Yuanjun Wu, Ziyi He
exaly   +3 more sources

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant Acinetobacter baumannii Infections—A Meta-Analysis

open access: yesAntibiotics
The addition of sulbactam restores the complete range of cefoperazone activity against bacteria and extends its spectrum of action to include the Acinetobacter species.
Chienhsiu Huang, Lichen Lin, Sufang Kuo
doaj   +2 more sources

Evaluating the Risk of Coagulopathy in Cephalosporins with Different Side Chains: A Propensity Score–Weighted Study [PDF]

open access: yesMedicina
Background and Objectives: Cephalosporins containing N-hydroxyethyltetrazolethiol (HTT) or N-methylthiotetrazole (NMTT) side chains, such as flomoxef and cefoperazone, have been linked to coagulation abnormalities.
Chien-Hsiang Tai   +2 more
doaj   +2 more sources

Efficacy and safety of Omadacycline in community-acquired pneumonia among elderly patients: a real-world evidence study [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
ObjectiveThis study aimed to evaluate real-world effectiveness and safety of omadacycline for elderly community-acquired pneumonia (CAP) versus tigecycline, moxifloxacin, and cefoperazone-sulbactam after inverse probability of treatment weighting (IPTW ...
Xinran Xie   +5 more
doaj   +2 more sources

Severe delayed coagulopathy caused by cefoperazone/sulbactam: A case report

open access: yesJournal of International Medical Research
This case report described a suspected severe coagulopathy attributed to cefoperazone/sulbactam, and this adverse reaction might be associated with the inhibition of the vitamin K cycle by cefoperazone/sulbactam, leading to vitamin K deficiency within ...
Siqin Sun   +4 more
doaj   +2 more sources

Antimicrobial Activity of Cefoperazone-Sulbactam Tested Against Gram-Negative Organisms From Europe, Asia-Pacific, and Latin America

open access: yesInternational Journal of Infectious Diseases, 2020
Objectives: To evaluate the antimicrobial activities of cefoperazone-sulbactam and comparator agents tested against a large collection of clinical isolates of Gram-negative organisms. Methods: A total of 19 545 Gram-negative organisms were collected from
Helio S Sader   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy